Burns Matteson Capital Management, LLC

Position in JNJ — Johnson & Johnson

CIK 1894164 CORNING, NY

Position in JNJ

as of Jun 30, 2026 · filed Jul 17, 2026 Compact

Position Value

$510,479

+$26,244 QoQ

Shares Held

2,010

+1.5% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.28%

of 13F equity value

Holder Rank

#3,686

of 4,676 holders

Holding Since

Dec 2020

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Burns Matteson Capital Management, LLC holds $3,433,998 across 5 Drug Manufacturers - General names. JNJ ranks #3 (14.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	1,163	$1,394,937
2	NVS	Novartis AG	3,477	$544,915
3	JNJ	Johnson & Johnson This page	2,010	$510,479
4	GSK	GSK plc	9,423	$493,953
5	PFE	Pfizer Inc	20,337	$489,714

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$510,479	2,010	+1.5%	Shares	Sole	2026-07-17
2026-03-31	$484,235	1,981	-0.7%	Shares	Sole	2026-05-15
2025-12-31	$412,658	1,994	+57.6%	Shares	Sole	2026-01-15
2023-06-30	$209,382	1,265	-8.2%	Shares	Sole	2023-12-12
2023-03-31	$213,590	1,378	-1.2%	Shares	Sole	2023-12-12
2022-12-31	$246,426	1,395	-2.1%	Shares	Sole	2023-12-12
2022-09-30	$232,788	1,425	-0.7%	Shares	Sole	2023-12-12
2022-06-30	$254,726	1,435	-3.0%	Shares	Sole	2023-12-12
2022-03-31	$262,300	1,480	-9.8%	Shares	Sole	2023-12-12
2021-12-31	$280,554	1,640	0.0%	Shares	Sole	2023-12-12
2021-09-30	$264,860	1,640	0.0%	Shares	Sole	2023-12-12
2021-06-30	$270,173	1,640	-2.4%	Shares	Sole	2023-12-12
2021-03-31	$276,108	1,680	+2.0%	Shares	Sole	2023-12-12
2020-12-31	$259,204	1,647	—	Shares	Sole	2023-12-12
No filing history on record for this holder in this stock.